person · Reporting owner

WALLMAN RICHARD F

Disclosed activity across 9 companies

Tapewire entity: 28640
SEC CIK: 0001198092

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
CECO ENVIRONMENTAL CORPCECO · Entity 4034	Director	June 01, 2026	June 03, 2026
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.CRL · Entity 3398	Director	November 06, 2024	November 12, 2024
CONVERGYS CORPCVG · Entity 163096	Director	November 10, 2017	November 14, 2017
ESH Hospitality, Inc.NONE · Entity 16193	Director	December 14, 2016	December 14, 2016
ROPER TECHNOLOGIES INCROP · Entity 3071	Director	July 24, 2026	July 27, 2026
SmileDirectClub, Inc.SDC · Entity 111962	Director	June 21, 2023	June 23, 2023
Spirit Aviation Holdings, Inc.SAVEQ · Entity 77286	Director	November 29, 2024	December 03, 2024

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

CECO ENVIRONMENTAL CORP

Report date June 01, 2026 · Filed June 03, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	233,352	Reported balance After 2026-06-01 transaction · row 1 1 source row Row 1 · 2026-06-01 · Grant · Acquired 3,443 · Balance 233,352 F1: Includes grant of 1,228 shares of common stock in lieu of annual cash fees paid to the director. F2: Shares will vest May 15, 2027.
Common StockSEC Table I · non-derivative	IndirectBy spouse	105,500	Reported balance After 2026-06-01 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 2 · 2026-06-01 · Purchase · Acquired 20,000 · Balance 105,500 F3: Price reflects the weighted average purchase price for multiple transactions that ranged from $75.00 to $78.75 per share. The Reporting Person undertakes to provide, upon request by the Commission Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.

Filing footnotes · ownership attribution and instrument terms

F1: Includes grant of 1,228 shares of common stock in lieu of annual cash fees paid to the director.

F2: Shares will vest May 15, 2027.

F3: Price reflects the weighted average purchase price for multiple transactions that ranged from $75.00 to $78.75 per share. The Reporting Person undertakes to provide, upon request by the Commission Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Report date November 06, 2024 · Filed November 12, 2024

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	12,386	Ending reported balance After 2024-11-07 transaction · row 3 3 source rows · reconciled sequence Row 1 · 2024-11-06 · Gift · Disposed 4,540 · Balance 19,007 Row 2 · 2024-11-07 · Sale · Disposed 3,371 · Balance 15,636 Row 3 · 2024-11-07 · Sale · Disposed 3,250 · Balance 12,386
Common StockSEC Table I · non-derivative	IndirectBy Wife	0	Reported balance After 2024-11-07 transaction · row 4 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 4 · 2024-11-07 · Sale · Disposed 1,000 · Balance 0

CONVERGYS CORP

Report date November 10, 2017 · Filed November 14, 2017

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common SharesSEC Table I · non-derivative	Direct	27,994	Reported balance After 2017-11-10 transaction · row 1 1 source row Row 1 · 2017-11-10 · Gift · Disposed 10,627 · Balance 27,994 F1: Represents a bona fide gift of common shares to a charitable donor-advised fund.

Filing footnotes · ownership attribution and instrument terms

F1: Represents a bona fide gift of common shares to a charitable donor-advised fund.

ESH Hospitality, Inc.

Report date December 14, 2016 · Filed December 14, 2016

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Paired SharesSEC Table I · non-derivative	Direct	111,100	Reported balance After 2016-12-14 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2016-12-14 · Gift · Disposed 18,042 · Balance 111,100 F1: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. F2: The reported transaction is a bona fide gift of Paired Shares to the Wallman Family Fund, a Fidelity Charitable donor-advised fund. A Form 4 reflecting the transaction in Paired Shares by the reporting person shown on this Form 4 has been concurrently filed with respect to Extended Stay America, Inc. as issuer.
Paired SharesSEC Table I · non-derivative	IndirectSee footnote	80,005	Reported balance Holding disclosure · report date 2016-12-14 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 80,005 F1: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. F3: These Paired Shares are held through the Richard F. Wallman IRA, an individual retirement account for which the reporting person is a fiduciary.
Paired SharesSEC Table I · non-derivative	IndirectSee footnote	9,800	Reported balance Holding disclosure · report date 2016-12-14 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 9,800 F1: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. F4: These Paired Shares are held through the Richard F. Wallman SEP, an individual retirement account for which the reporting person is a fiduciary.
Paired SharesSEC Table I · non-derivative	IndirectSpouse IRA	13,800	Reported balance Holding disclosure · report date 2016-12-14 · row 4 Holding and transaction disclosures are not merged. 1 source row Row 4 · Balance 13,800 F1: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit.
Paired SharesSEC Table I · non-derivative	IndirectSpouse SEP	18,200	Reported balance Holding disclosure · report date 2016-12-14 · row 5 Holding and transaction disclosures are not merged. 1 source row Row 5 · Balance 18,200 F1: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit.

Filing footnotes · ownership attribution and instrument terms

F2: The reported transaction is a bona fide gift of Paired Shares to the Wallman Family Fund, a Fidelity Charitable donor-advised fund. A Form 4 reflecting the transaction in Paired Shares by the reporting person shown on this Form 4 has been concurrently filed with respect to Extended Stay America, Inc. as issuer.

F3: These Paired Shares are held through the Richard F. Wallman IRA, an individual retirement account for which the reporting person is a fiduciary.

F4: These Paired Shares are held through the Richard F. Wallman SEP, an individual retirement account for which the reporting person is a fiduciary.

ROPER TECHNOLOGIES INC

Report date July 24, 2026 · Filed July 27, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	7,423	Reported balance After 2026-07-24 transaction · row 1 1 source row Row 1 · 2026-07-24 · Sale · Disposed 6,434 · Balance 7,423

SmileDirectClub, Inc.

Report date June 21, 2023 · Filed June 23, 2023

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	Direct	336,318	Reported balance After 2023-06-21 transaction · row 1 1 source row Row 1 · 2023-06-21 · Sale · Disposed 135,135 · Balance 336,318 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.4237 to $0.4500, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote 1 to Form 4.

Filing footnotes · ownership attribution and instrument terms

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.4237 to $0.4500, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote 1 to Form 4.

Spirit Aviation Holdings, Inc.

Report date November 29, 2024 · Filed December 03, 2024

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	28,513	Reported balance After 2024-11-29 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2024-11-29 · Sale · Disposed 2,000 · Balance 28,513 F1: Includes restricted stock units.

Filing footnotes · ownership attribution and instrument terms

F1: Includes restricted stock units.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Extended Stay America, Inc.

Report date May 13, 2021 · Filed June 21, 2021

Section 16 reporting ended · disclosed 2021-06-21. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Paired SharesSEC Table I · non-derivative	Direct	Last balance in matching sequence After 2021-06-16 transaction · row 2 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 2 source rows Row 1 · 2021-05-13 · Disposition to issuer · Disposed 139,116 · Balance 8,968 F1: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. This Form 4 is being filed in connection with the merger ("Merger") of a wholly-owned subsidiary of Eagle Parent Holdings L.P. ("Eagle") with and into the Issuer, pursuant to the terms of the certain Agreement and Plan of Merger, dated as of March 14, 2021 (the "Merger Agreement"), between the Issuer and Eagle. The Merger closed on June 16, 2021. F2: The reported transaction is a bona fide gift of Paired Shares to the Wallman Family Fund, a Fidelity Charitable donor-advised fund. This is not a market transaction, thus no price has been reported. No value was received for the gifted shares. Row 2 · 2021-06-16 · Disposition to issuer · Disposed 8,968 · Balance 0 F1: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. This Form 4 is being filed in connection with the merger ("Merger") of a wholly-owned subsidiary of Eagle Parent Holdings L.P. ("Eagle") with and into the Issuer, pursuant to the terms of the certain Agreement and Plan of Merger, dated as of March 14, 2021 (the "Merger Agreement"), between the Issuer and Eagle. The Merger closed on June 16, 2021. F3: Each Paired Share held directly or indirectly by the reporting person at the effective time of the Merger was disposed of for $18.75 in cash, pursuant to the terms of the Merger Agreement. This price does not include the special dividend of $1.75 per Paired Share that the reporting person has the right to receive in connection with the consummation of the Merger.
Paired SharesSEC Table I · non-derivative	IndirectSee footnote	Reported balance After 2021-06-16 transaction · row 3 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 3 · 2021-06-16 · Disposition to issuer · Disposed 60,005 · Balance 0 F1: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. This Form 4 is being filed in connection with the merger ("Merger") of a wholly-owned subsidiary of Eagle Parent Holdings L.P. ("Eagle") with and into the Issuer, pursuant to the terms of the certain Agreement and Plan of Merger, dated as of March 14, 2021 (the "Merger Agreement"), between the Issuer and Eagle. The Merger closed on June 16, 2021. F3: Each Paired Share held directly or indirectly by the reporting person at the effective time of the Merger was disposed of for $18.75 in cash, pursuant to the terms of the Merger Agreement. This price does not include the special dividend of $1.75 per Paired Share that the reporting person has the right to receive in connection with the consummation of the Merger. F4: These Paired Shares are held through the Richard F. Wallman IRA, an individual retirement account for which he is a fiduciary.
Paired SharesSEC Table I · non-derivative	IndirectSee footnote	Reported balance After 2021-06-16 transaction · row 4 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 4 · 2021-06-16 · Disposition to issuer · Disposed 9,800 · Balance 0 F1: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. This Form 4 is being filed in connection with the merger ("Merger") of a wholly-owned subsidiary of Eagle Parent Holdings L.P. ("Eagle") with and into the Issuer, pursuant to the terms of the certain Agreement and Plan of Merger, dated as of March 14, 2021 (the "Merger Agreement"), between the Issuer and Eagle. The Merger closed on June 16, 2021. F3: Each Paired Share held directly or indirectly by the reporting person at the effective time of the Merger was disposed of for $18.75 in cash, pursuant to the terms of the Merger Agreement. This price does not include the special dividend of $1.75 per Paired Share that the reporting person has the right to receive in connection with the consummation of the Merger. F5: These Paired Shares are held through the Richard F. Wallman SEP, an individual retirement account for which he is a fiduciary.
Paired SharesSEC Table I · non-derivative	IndirectSpouseIRA	Reported balance After 2021-06-16 transaction · row 5 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 5 · 2021-06-16 · Disposition to issuer · Disposed 13,800 · Balance 0 F1: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. This Form 4 is being filed in connection with the merger ("Merger") of a wholly-owned subsidiary of Eagle Parent Holdings L.P. ("Eagle") with and into the Issuer, pursuant to the terms of the certain Agreement and Plan of Merger, dated as of March 14, 2021 (the "Merger Agreement"), between the Issuer and Eagle. The Merger closed on June 16, 2021. F3: Each Paired Share held directly or indirectly by the reporting person at the effective time of the Merger was disposed of for $18.75 in cash, pursuant to the terms of the Merger Agreement. This price does not include the special dividend of $1.75 per Paired Share that the reporting person has the right to receive in connection with the consummation of the Merger.
Paired SharesSEC Table I · non-derivative	IndirectSpouseSEP	Reported balance After 2021-06-16 transaction · row 6 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 6 · 2021-06-16 · Disposition to issuer · Disposed 18,200 · Balance 0 F1: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. This Form 4 is being filed in connection with the merger ("Merger") of a wholly-owned subsidiary of Eagle Parent Holdings L.P. ("Eagle") with and into the Issuer, pursuant to the terms of the certain Agreement and Plan of Merger, dated as of March 14, 2021 (the "Merger Agreement"), between the Issuer and Eagle. The Merger closed on June 16, 2021. F3: Each Paired Share held directly or indirectly by the reporting person at the effective time of the Merger was disposed of for $18.75 in cash, pursuant to the terms of the Merger Agreement. This price does not include the special dividend of $1.75 per Paired Share that the reporting person has the right to receive in connection with the consummation of the Merger.

Filing footnotes · ownership attribution and instrument terms

F1: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. This Form 4 is being filed in connection with the merger ("Merger") of a wholly-owned subsidiary of Eagle Parent Holdings L.P. ("Eagle") with and into the Issuer, pursuant to the terms of the certain Agreement and Plan of Merger, dated as of March 14, 2021 (the "Merger Agreement"), between the Issuer and Eagle. The Merger closed on June 16, 2021.

F2: The reported transaction is a bona fide gift of Paired Shares to the Wallman Family Fund, a Fidelity Charitable donor-advised fund. This is not a market transaction, thus no price has been reported. No value was received for the gifted shares.

F3: Each Paired Share held directly or indirectly by the reporting person at the effective time of the Merger was disposed of for $18.75 in cash, pursuant to the terms of the Merger Agreement. This price does not include the special dividend of $1.75 per Paired Share that the reporting person has the right to receive in connection with the consummation of the Merger.

F4: These Paired Shares are held through the Richard F. Wallman IRA, an individual retirement account for which he is a fiduciary.

F5: These Paired Shares are held through the Richard F. Wallman SEP, an individual retirement account for which he is a fiduciary.

Wright Medical Group N.V.

Report date November 11, 2020 · Filed November 13, 2020

Section 16 reporting ended · disclosed 2020-11-13. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Ordinary Shares, par value EUR 0.03 per shareSEC Table I · non-derivative	Direct	Reported balance After 2020-11-11 transaction · row 1 1 source row Row 1 · 2020-11-11 · Other · Disposed 12,697 · Balance 0 F1: On November 4, 2019, Wright Medical Group N.V. (the Issuer) entered into a purchase agreement (the Purchase Agreement) with Stryker Corporation and its subsidiary, Stryker B.V. (the Purchaser). Pursuant to the terms of the Purchase Agreement, the Purchaser commenced a tender offer for all the outstanding ordinary shares, par value EUR 0.03 per share (Shares), of the Issuer (the Offer), and on November 11, 2020 (the Acceptance Time), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer, including 12,697 Shares tendered by the reporting person, in exchange for a cash payment equal to $30.75 per Share, without interest and less applicable withholding taxes (the Offer Consideration), which Offer Consideration will be paid as promptly as practicable following the Closing (as defined in the Purchase Agreement).
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $27.84 · Expires 2029-07-26	Direct	Reported balance After 2020-11-11 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2020-11-11 · Disposition to issuer · Disposed 11,691 · Balance 0 F2: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a Wright Stock Option) that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $24.49 · Expires 2028-07-24	Direct	Reported balance After 2020-11-11 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2020-11-11 · Disposition to issuer · Disposed 9,907 · Balance 0 F2: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a Wright Stock Option) that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $27.86 · Expires 2027-07-25	Direct	Reported balance After 2020-11-11 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2020-11-11 · Disposition to issuer · Disposed 10,275 · Balance 0 F2: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a Wright Stock Option) that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $21.24 · Expires 2026-07-19	Direct	Reported balance After 2020-11-11 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2020-11-11 · Disposition to issuer · Disposed 11,765 · Balance 0 F2: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a Wright Stock Option) that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $25.20 · Expires 2021-05-12	Direct	Reported balance After 2020-11-11 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2020-11-11 · Disposition to issuer · Disposed 7,800 · Balance 0 F2: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a Wright Stock Option) that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes.

Filing footnotes · ownership attribution and instrument terms

F1: On November 4, 2019, Wright Medical Group N.V. (the Issuer) entered into a purchase agreement (the Purchase Agreement) with Stryker Corporation and its subsidiary, Stryker B.V. (the Purchaser). Pursuant to the terms of the Purchase Agreement, the Purchaser commenced a tender offer for all the outstanding ordinary shares, par value EUR 0.03 per share (Shares), of the Issuer (the Offer), and on November 11, 2020 (the Acceptance Time), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer, including 12,697 Shares tendered by the reporting person, in exchange for a cash payment equal to $30.75 per Share, without interest and less applicable withholding taxes (the Offer Consideration), which Offer Consideration will be paid as promptly as practicable following the Closing (as defined in the Purchase Agreement).

F2: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a Wright Stock Option) that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
December 10, 2018 Filed Dec 11, 2018 16:03 UTC	Wright Medical Group N.V. WMGI · Entity 145358	PurchaseOrdinary Shares, par value EUR 0.03 per share	20,000	$26.83	$536,600.00	Disclosure SEC source: 0001235802-18-000177 · primary_doc.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,578 F1 · balance_after: Includes 6,731 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan. F2 · balance_after: Total holdings were increased by one ordinary share due to a rounding error in the Form 4 report that was filed with the SEC on July 26, 2018. Read SEC document
October 04, 2018 Filed Oct 5, 2018 20:50 UTC	Extended Stay America, Inc. STAY · Entity 16197	GrantPaired Shares	1,323	$19.85	$26,261.55	Disclosure SEC source: 0001567619-18-003764 · doc1.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,121 F1 · security: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. F2 · shares: These Paired Shares were acquired in lieu of the reporting person's quarterly cash retainer for the third quarter of 2018. Read SEC document
September 20, 2018 Filed Sep 24, 2018 21:07 UTC	ROPER TECHNOLOGIES INC ROP · Entity 3071	GrantCommon Stock	500	$308.85	$154,425.00	Disclosure SEC source: 0001209191-18-052054 · doc4.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 500 Read SEC document
September 14, 2018 Filed Sep 14, 2018 18:22 UTC	ROPER TECHNOLOGIES INC ROP · Entity 3071	PurchaseCommon Stock	500	$312.35	$156,175.00	Disclosure SEC source: 0001209191-18-051007 · doc4.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,965 Read SEC document
August 02, 2018 Filed Aug 3, 2018 22:39 UTC	Extended Stay America, Inc. STAY · Entity 16197	SalePaired Shares	15,000	$21.49	$322,375.50	Disclosure SEC source: 0001140361-18-035450 · doc1.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,798 F1 · security: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.47 to $21.55, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote . Read SEC document
July 27, 2018 Filed Jul 27, 2018 19:23 UTC	ROPER TECHNOLOGIES INC ROP · Entity 3071	PurchaseCommon Stock	500	$299.50	$149,750.00	Disclosure SEC source: 0001209191-18-044178 · doc4.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,465 Read SEC document
July 25, 2018 Filed Jul 26, 2018 21:16 UTC	Wright Medical Group N.V. WMGI · Entity 145358	Tax withholdingOrdinary Shares, par value EUR 0.03 per share	626	$24.83	$15,543.58	Disclosure SEC source: 0001235802-18-000116 · primary_doc.xml · nonDerivative · entry 3 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,577 F4 · balance_after: Includes 7,706 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan. Read SEC document
July 24, 2018 Filed Jul 26, 2018 21:16 UTC	Wright Medical Group N.V. WMGI · Entity 145358	GrantStock Option (right to buy) · Derivative	9,907	$0.00 Strike: $24.49	$0.00	Disclosure SEC source: 0001235802-18-000116 · primary_doc.xml · derivative · entry 4 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,907 Underlying: Ordinary Shares · 9,907 shares Expires 2028-07-24 F5 · derivative.exercise_date: This option vests in two annual installments, on the one-year and two-year anniversaries of July 24, 2018. Read SEC document
July 24, 2018 Filed Jul 26, 2018 21:16 UTC	Wright Medical Group N.V. WMGI · Entity 145358	GrantOrdinary Shares, par value EUR 0.03 per share	3,902	$25.63	$100,008.26	Disclosure SEC source: 0001235802-18-000116 · primary_doc.xml · nonDerivative · entry 2 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,203 F2 · shares: These ordinary shares will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan, in lieu of retainer fees in the aggregate amount of $100,000. F3 · balance_after: Includes 11,292 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan. Read SEC document
July 24, 2018 Filed Jul 26, 2018 21:16 UTC	Wright Medical Group N.V. WMGI · Entity 145358	GrantOrdinary Shares, par value EUR 0.03 per share	3,804	$0.00	$0.00	Disclosure SEC source: 0001235802-18-000116 · primary_doc.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,301 F1 · shares: These ordinary shares will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan. Read SEC document
July 05, 2018 Filed Jul 6, 2018 20:11 UTC	Extended Stay America, Inc. STAY · Entity 16197	GrantPaired Shares	1,207	$21.76	$26,264.32	Disclosure SEC source: 0001140361-18-031780 · doc1.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,798 F1 · security: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. F2 · shares: These Paired Shares were acquired in lieu of the reporting person's quarterly cash retainer for the second quarter of 2018. Read SEC document
June 30, 2018 Filed Jul 2, 2018 16:16 UTC	Wright Medical Group N.V. WMGI · Entity 145358	Tax withholdingOrdinary Shares, par value EUR 0.03 per share	274	$25.96	$7,113.04	Disclosure SEC source: 0001235802-18-000086 · primary_doc.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,497 F1 · balance_after: Includes 3,586 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan. Read SEC document
June 05, 2018 Filed Jun 7, 2018 21:04 UTC	ROPER TECHNOLOGIES INC ROP · Entity 3071	GrantCommon Stock	3,000	$0.00	$0.00	Disclosure SEC source: 0001209191-18-036420 · doc4.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,965 F1 · shares: The securities reported are restricted stock units granted to the reporting person, pursuant to the Director Compensation Plan, and each restricted stock unit represents a contingent right to receive one share of Roper Technologies, Inc. common stock. The restricted stock units vest 50% on the 6-month anniversary of the grant date and 50% on the day prior to the 2019 Annual Meeting of Shareholders. Read SEC document
May 23, 2018 Filed May 23, 2018 20:17 UTC	ROPER TECHNOLOGIES INC ROP · Entity 3071	PurchaseCommon Stock	500	$278.00	$139,000.00	Disclosure SEC source: 0001209191-18-032582 · doc4.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,965 Read SEC document
May 15, 2018 Filed May 17, 2018 20:12 UTC	Extended Stay America, Inc. STAY · Entity 16197	GrantPaired Shares	5,033	$0.00	$0.00	Disclosure SEC source: 0001140361-18-024419 · doc1.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,591 F1 · security: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. F2 · kind: The reported transaction is an award of Restricted Stock Units in respect of Paired Shares. Subject to the reporting person's continued service as a director of the issuer through the vesting date, these Restricted Stock Units are scheduled to vest in full on May 15, 2019. Vested Restricted Stock Units will be settled in Paired Shares on the September 15th next following the vesting date (or, in any year when the 15th of September falls on a non-business day, the business day immediately prior to such date). Read SEC document
May 14, 2018 Filed May 15, 2018 19:55 UTC	CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398	GrantCommon Stock	676	$0.00	$0.00	Disclosure SEC source: 0001127602-18-017511 · form4.xml · nonDerivative · entry 2 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,928 F2 · kind: This grant was made in lieu of director service fees for the term commencing May 8, 2018. The restricted stock units vest upon the earlier of 5/14/2019 or the business day prior to the Company's next annual meeting of shareholders. Read SEC document
May 14, 2018 Filed May 15, 2018 19:55 UTC	CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398	GrantCommon Stock	2,004	$0.00	$0.00	Disclosure SEC source: 0001127602-18-017511 · form4.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,252 F1 · kind: Consists of 2,004 unvested restricted stock units that vest upon the earlier of 5/14/2019, or the business day prior to the Company's next annual meeting of shareholders. Read SEC document
May 14, 2018 Filed May 25, 2018 01:00 UTC Amendment	CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398	GrantCommon Stock	653	$0.00	$0.00	Disclosure SEC source: 0001127602-18-018890 · form4a.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,905 F1 · shares: Due to an administrative error, the original Form 4 filed on May 15, 2018, incorrectly reported the number of restricted stock units granted. The correct number of restricted stock unit awards granted is listed on this amended Form 4. Read SEC document
April 05, 2018 Filed Apr 6, 2018 20:37 UTC	Extended Stay America, Inc. STAY · Entity 16197	GrantPaired Shares	1,337	$19.72	$26,365.64	Disclosure SEC source: 0001140361-18-017642 · doc1.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,558 F1 · security: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. F2 · shares: These Paired Shares were acquired in lieu of the reporting person's quarterly cash retainer for the first quarter of 2018. Read SEC document
March 31, 2018 Filed Apr 3, 2018 16:32 UTC	Wright Medical Group N.V. WMGI · Entity 145358	Tax withholdingOrdinary Shares, par value EUR 0.03 per share	256	$19.84	$5,079.04	Disclosure SEC source: 0001235802-18-000049 · primary_doc.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,771 F1 · balance_after: Includes 4,506 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan. Read SEC document
March 12, 2018 Filed Mar 13, 2018 20:08 UTC	ROPER TECHNOLOGIES INC ROP · Entity 3071	PurchaseCommon Stock	500	$282.59	$141,295.00	Disclosure SEC source: 0001209191-18-019170 · doc4.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,465 Read SEC document
January 04, 2018 Filed Jan 8, 2018 21:52 UTC	Extended Stay America, Inc. STAY · Entity 16197	GrantPaired Shares	1,453	$18.06	$26,236.82	Disclosure SEC source: 0001140361-18-001245 · doc1.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,221 F1 · security: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. F2 · shares: These Paired Shares were acquired in lieu of the reporting person's quarterly cash retainer for the fourth quarter of 2017. Read SEC document
December 31, 2017 Filed Jan 3, 2018 16:58 UTC	Wright Medical Group N.V. WMGI · Entity 145358	Tax withholdingOrdinary Shares, par value EUR 0.03 per share	265	$22.20	$5,883.00	Disclosure SEC source: 0001235802-18-000006 · primary_doc.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,027 F1 · balance_after: Includes 5,425 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan. Read SEC document
November 10, 2017 Filed Nov 14, 2017 16:36 UTC	CONVERGYS CORP CVG · Entity 163096	GiftCommon Shares	10,627	$0.00	$0.00	Disclosure SEC source: 0001209191-17-060618 · doc4.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,994 F1 · kind: Represents a bona fide gift of common shares to a charitable donor-advised fund. Read SEC document
November 10, 2017 Filed Nov 14, 2017 16:15 UTC	Wright Medical Group N.V. WMGI · Entity 145358	PurchaseOrdinary Shares, par value EUR 0.03 per share	72	$24.01	$1,728.72	Disclosure SEC source: 0001235802-17-000167 · primary_doc.xml · nonDerivative · entry 3 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,292 F1 · balance_after: Includes 6,345 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan. Read SEC document
November 10, 2017 Filed Nov 14, 2017 16:15 UTC	Wright Medical Group N.V. WMGI · Entity 145358	PurchaseOrdinary Shares, par value EUR 0.03 per share	3,328	$24.00	$79,872.00	Disclosure SEC source: 0001235802-17-000167 · primary_doc.xml · nonDerivative · entry 2 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,220 F1 · balance_after: Includes 6,345 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan. Read SEC document
November 10, 2017 Filed Nov 14, 2017 16:15 UTC	Wright Medical Group N.V. WMGI · Entity 145358	PurchaseOrdinary Shares, par value EUR 0.03 per share	600	$23.98	$14,388.00	Disclosure SEC source: 0001235802-17-000167 · primary_doc.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,892 F1 · balance_after: Includes 6,345 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan. Read SEC document
November 03, 2017 Filed Nov 6, 2017 20:44 UTC	Wright Medical Group N.V. WMGI · Entity 145358	Exercise / conversionStock Option (right to buy) · Derivative	11,018	$20.62 Strike: $20.62	$227,191.16	Disclosure SEC source: 0001235802-17-000163 · primary_doc.xml · derivative · entry 8 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 11,018 shares Expires 2025-10-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
November 03, 2017 Filed Nov 6, 2017 20:44 UTC	Wright Medical Group N.V. WMGI · Entity 145358	Exercise / conversionOrdinary Shares, par value EUR 0.03 per share	11,018	$20.62	$227,191.16	Disclosure SEC source: 0001235802-17-000163 · primary_doc.xml · nonDerivative · entry 4 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,292 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 6,345 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan. Read SEC document
November 02, 2017 Filed Nov 6, 2017 20:44 UTC	Wright Medical Group N.V. WMGI · Entity 145358	Exercise / conversionStock Option (right to buy) · Derivative	6,034	$21.66 Strike: $21.66	$130,696.44	Disclosure SEC source: 0001235802-17-000163 · primary_doc.xml · derivative · entry 7 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,034 shares Expires 2024-08-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
November 02, 2017 Filed Nov 6, 2017 20:44 UTC	Wright Medical Group N.V. WMGI · Entity 145358	Exercise / conversionStock Option (right to buy) · Derivative	7,538	$19.45 Strike: $19.45	$146,614.10	Disclosure SEC source: 0001235802-17-000163 · primary_doc.xml · derivative · entry 6 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 7,538 shares Expires 2023-08-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
November 02, 2017 Filed Nov 6, 2017 20:44 UTC	Wright Medical Group N.V. WMGI · Entity 145358	Exercise / conversionStock Option (right to buy) · Derivative	6,448	$18.04 Strike: $18.04	$116,321.92	Disclosure SEC source: 0001235802-17-000163 · primary_doc.xml · derivative · entry 5 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shraes · 6,448 shares Expires 2022-08-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
November 02, 2017 Filed Nov 6, 2017 20:44 UTC	Wright Medical Group N.V. WMGI · Entity 145358	Exercise / conversionOrdinary Shares, par value EUR 0.03 per share	6,034	$21.66	$130,696.44	Disclosure SEC source: 0001235802-17-000163 · primary_doc.xml · nonDerivative · entry 3 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,274 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 6,345 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan. Read SEC document
November 02, 2017 Filed Nov 6, 2017 20:44 UTC	Wright Medical Group N.V. WMGI · Entity 145358	Exercise / conversionOrdinary Shares, par value EUR 0.03 per share	7,538	$19.45	$146,614.10	Disclosure SEC source: 0001235802-17-000163 · primary_doc.xml · nonDerivative · entry 2 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,240 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 6,345 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan. Read SEC document
November 02, 2017 Filed Nov 6, 2017 20:44 UTC	Wright Medical Group N.V. WMGI · Entity 145358	Exercise / conversionOrdinary Shares, par value EUR 0.03 per share	6,448	$18.04	$116,321.92	Disclosure SEC source: 0001235802-17-000163 · primary_doc.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,702 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 6,345 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan. Read SEC document
September 30, 2017 Filed Oct 2, 2017 16:08 UTC	Wright Medical Group N.V. WMGI · Entity 145358	Tax withholdingOrdinary Shares, par value EUR 0.03 per share	208	$25.87	$5,380.96	Disclosure SEC source: 0001235802-17-000150 · primary_doc.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,254 F1 · balance_after: Includes 6,345 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan. Read SEC document
July 25, 2017 Filed Jul 26, 2017 17:24 UTC	Wright Medical Group N.V. WMGI · Entity 145358	GrantStock Option (right to buy) · Derivative	10,275	$0.00 Strike: $27.86	$0.00	Disclosure SEC source: 0001235802-17-000124 · primary_doc.xml · derivative · entry 3 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,275 Underlying: Ordinary Shares · 10,275 shares Expires 2027-07-25 F4 · derivative.exercise_date: This option vests in two annual installments, on the one-year and two-year anniversaries of July 25, 2017. Read SEC document
July 25, 2017 Filed Jul 26, 2017 17:24 UTC	Wright Medical Group N.V. WMGI · Entity 145358	GrantOrdinary Shares, par value EUR 0.03 per share	3,678	$27.19	$100,004.82	Disclosure SEC source: 0001235802-17-000124 · primary_doc.xml · nonDerivative · entry 2 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,462 F2 · shares: These ordinary shares will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan, in lieu of retainer fees in the aggregate amount of $100,000. F3 · balance_after: Includes 7,264 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan. Read SEC document
July 25, 2017 Filed Jul 26, 2017 17:24 UTC	Wright Medical Group N.V. WMGI · Entity 145358	GrantOrdinary Shares, par value EUR 0.03 per share	3,586	$0.00	$0.00	Disclosure SEC source: 0001235802-17-000124 · primary_doc.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,784 F1 · shares: These ordinary shares will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan. Read SEC document
July 19, 2017 Filed Jul 21, 2017 16:35 UTC	Wright Medical Group N.V. WMGI · Entity 145358	Tax withholdingOrdinary Shares, par value EUR 0.03 per share	1,428	$27.58	$39,384.24	Disclosure SEC source: 0001235802-17-000112 · primary_doc.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,198 Read SEC document
June 09, 2017 Filed Jun 13, 2017 21:31 UTC	ROPER TECHNOLOGIES INC ROP · Entity 3071	GrantCommon Stock	4,000	$0.00	$0.00	Disclosure SEC source: 0001209191-17-039597 · doc4.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,965 F1 · shares: The securities reported are restricted stock units granted to the reporting person, pursuant to the Director Compensation Plan, and each restricted stock unit represents a contingent right to receive one share of Roper Technologies, Inc. common stock. The restricted stock units vest 50% on the 6-month anniversary of the grant date and 50% on the day prior to the 2018 Annual Meeting of Shareholders. Read SEC document
May 17, 2017 Filed May 19, 2017 21:21 UTC	Extended Stay America, Inc. STAY · Entity 16197	GrantPaired Shares	5,668	$0.00	$0.00	Disclosure SEC source: 0001140361-17-021623 · doc1.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,768 F1 · security: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. F2 · kind: The reported transaction is an award of Restricted Stock Units in respect of Paired Shares. Subject to the reporting person's continued service as a director of the issuer through the applicable vesting date, these Restricted Stock Units are scheduled to vest in full on May 17, 2018. Vested Restricted Stock Units will be settled in Paired Shares on the September 15th next following the applicable vesting date (or, in any year when the 15th of September falls on a non-business day, the business day immediately prior to such date). Read SEC document
May 15, 2017 Filed May 17, 2017 17:06 UTC	CONVERGYS CORP CVG · Entity 163096	GrantCommon Shares	5,195	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-17-033223 · doc4.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,621 F1 · price: Award of time-based restricted stock units. Read SEC document
May 12, 2017 Filed May 15, 2017 19:23 UTC	CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398	GrantCommon Stock	822	$0.00	$0.00	Disclosure SEC source: 0001127602-17-018054 · form4.xml · nonDerivative · entry 2 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,248 F2 · kind: This grant was made in lieu of director services fees for the term commencing May 9, 2017, and includes the fee he receives for being Chair of the Finance Committee, which was established on January 1, 2017. The restricted stock units vest upon the earlier of 5/12/2018, or the business day prior to the Company's next annual meeting of shareholders. Read SEC document
May 12, 2017 Filed May 15, 2017 19:23 UTC	CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398	GrantCommon Stock	2,436	$0.00	$0.00	Disclosure SEC source: 0001127602-17-018054 · form4.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,426 F1 · kind: Consists of 2,436 unvested restricted stock units that vest upon the earlier of May 12, 2018, or the business day prior to the Company's next annual meeting of shareholders. Read SEC document
February 22, 2017 Filed Feb 23, 2017 16:27 UTC	Wright Medical Group N.V. WMGI · Entity 145358	Exercise / conversionStock Option (right to buy) · Derivative	16,375	$16.98 Strike: $16.98	$278,047.50	Disclosure SEC source: 0001235802-17-000028 · primary_doc.xml · derivative · entry 3 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 16,375 shares Expires 2018-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale of shares reported on this Form 4 were effected under a pre-arranged Rule 10b5-1 trading plan adopted by the reporting person on August 5, 2016. F3 · derivative.exercise_date: This option fully vested on December 8, 2012. Read SEC document
February 22, 2017 Filed Feb 23, 2017 16:27 UTC	Wright Medical Group N.V. WMGI · Entity 145358	SaleOrdinary Shares, par value EUR 0.03 per share	16,375	$28.25	$462,593.75	Disclosure SEC source: 0001235802-17-000028 · primary_doc.xml · nonDerivative · entry 2 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,626 F1 · kind: The option exercise and sale of shares reported on this Form 4 were effected under a pre-arranged Rule 10b5-1 trading plan adopted by the reporting person on August 5, 2016. F2 · balance_after: Includes 4,094 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan. Read SEC document
February 22, 2017 Filed Feb 23, 2017 16:27 UTC	Wright Medical Group N.V. WMGI · Entity 145358	Exercise / conversionOrdinary Shares, par value EUR 0.03 per share	16,375	$16.98	$278,047.50	Disclosure SEC source: 0001235802-17-000028 · primary_doc.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,001 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale of shares reported on this Form 4 were effected under a pre-arranged Rule 10b5-1 trading plan adopted by the reporting person on August 5, 2016. F2 · balance_after: Includes 4,094 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan. Read SEC document
February 08, 2017 Filed Feb 9, 2017 16:27 UTC	Wright Medical Group N.V. WMGI · Entity 145358	Exercise / conversionStock Option (right to buy) · Derivative	9,000	$16.98 Strike: $16.98	$152,820.00	Disclosure SEC source: 0001235802-17-000027 · primary_doc.xml · derivative · entry 3 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,375 Underlying: Ordinary Shares · 9,000 shares Expires 2018-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale of shares reported on this Form 4 were effected under a pre-arranged Rule 10b5-1 trading plan adopted by the reporting person on August 5, 2016. F3 · derivative.exercise_date: This option fully vested on December 8, 2012. Read SEC document
February 08, 2017 Filed Feb 9, 2017 16:27 UTC	Wright Medical Group N.V. WMGI · Entity 145358	SaleOrdinary Shares, par value EUR 0.03 per share	9,000	$26.25	$236,250.00	Disclosure SEC source: 0001235802-17-000027 · primary_doc.xml · nonDerivative · entry 2 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,626 F1 · kind: The option exercise and sale of shares reported on this Form 4 were effected under a pre-arranged Rule 10b5-1 trading plan adopted by the reporting person on August 5, 2016. F2 · balance_after: Includes 4,094 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.